MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0002412
Marc Laboratories Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹202.58 Cr
▲ 3% YoY
Net profit · FY 2025
₹9.63 Cr
Net margin 4.8%
EBITDA · FY 2025
₹37.08 Cr
EBITDA margin 18.3%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹5.53 Cr
Issued & subscribed
Open charges
₹155.67 Cr
Satisfied ₹123.09 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
341
Provident fund records
About Marc Laboratories Limited
Data last updated:
Marc Laboratories Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U72200DL1985PLC020782. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.53 Cr. It was formerly known as Marc Laboratories Private Limited. It is led by directors including Kapil Dev Mahto and Amit Kishore Rastogi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 5 Bn Block (W) Central Market Iind Floor Adjoining Bank Of Baroda Sha, Limar Bagh, New Delhi, Delhi, India – 110088.
As per the financials filed for FY 2025, the company reported a revenue of ₹202.58 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹9.63 Cr (net margin 4.8%) and EBITDA of ₹37.08 Cr (EBITDA margin 18.3%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 25% over five years.
The company has about 341 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 2 brands: Marc Laboratories and MarcCure. As per MCA filings, the company has open charges of ₹155.67 Cr and satisfied charges of ₹123.09 Cr on record. Court records list 47 cases involving the company, including 41 filed by the company and 6 filed against it; 19 cases are pending. The company has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹3.35 Cr; the latest was in November 2024. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Rusan Pharma Limited with revenue of ₹392.15 Cr.
Marc Laboratories Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002412). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website marclabs.in.
Company details
CIN U72200DL1985PLC020782
Registration Number 020782
Incorporation Date 25 April 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0002412
CIN history
Marc Laboratories has one previous CIN (Corporate Identification Number): U74899DL1985PLC020782. The current CIN is U72200DL1985PLC020782, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200DL1985PLC020782 | Current |
| U74899DL1985PLC020782 | Previous |
Recognitions & Rankings of Marc Laboratories
Contact details
Marc Laboratories Limited's registered office is in New Delhi, Delhi. Its website is marclabs.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. – 5 Bn Block (W) Central Market Iind Floor Adjoining Bank Of Baroda Sha, Limar Bagh, New Delhi, Delhi, India – 110088
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Marc Laboratories Limited, buy the company report.
Comprehensive company report
Marc Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Marc Laboratories operates two associated brands: Marc Laboratories and MarcCure. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical products, research, development, and infrastructure services. | marclabs.in | |
| Ayurvedic medicine manufacturing and online sales in India. | marccure.com |
Business activity
The main business activities of Marc Laboratories are manufacturing and information and communication. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other information & communication service activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Marc Laboratories Limited, buy the company report.
Financials of Marc Laboratories Limited
FY 2025 filings availableMarc Laboratories Limited reported revenue of ₹202.58 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹202.58 Cr ▲ 3%
Net profit · FY 2025
₹9.63 Cr margin 4.8%
EBITDA · FY 2025
₹37.08 Cr margin 18.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 36%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 47%
5 years · compounded
▲ 23%
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 3% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹202.58 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37.08 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.63 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.3% | ||||
| Net Profit Margin | 4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Marc Laboratories Limited, buy the company report.
Board of directors of Marc Laboratories Limited
Marc Laboratories has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kapil Dev Mahto | Director | 15 Apr 2023 | 3 Years 6 Months | Current |
| Amit Kishore Rastogi | Director | 01 Feb 2001 | 25 Years 9 Months | Current |
| Vipin Kishore Rastogi Also directs: Healers Lab Limited, Barrhgarh Hydro Power Project Private Limited, Marc India Limited and 1 more | Director | 20 Mar 2023 | 3 Years 7 Months | Current |
| Prem Kishore Rastogi Also directs: Healers Lab Limited, Scanners Infotech Private Limited | Director | 25 Apr 1985 | 41 Years 6 Months | Current |
| Akhilesh Kumar Srivastava Also directs: Simus Laboratories Private Limited | Director | 15 Apr 2023 | 3 Years 6 Months | Current |
| Nitin Kishore Rastogi | Director | 20 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Marc Laboratories Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rusan Pharma Limited | ₹392.15 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Zim Laboratories Limited. | ₹384.82 Cr (FY 2025) | 3.0% | Nagpur, Maharashtra, India | |||
| Rajasthan Antibiotics Ltd | ₹383.3 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Caplin Steriles Limited | ₹377.24 Cr (FY 2025) | 18.0% | Chennai, Tamil Nadu, India | |||
| Unicure India Ltd | ₹369.12 Cr (FY 2025) | -12.0% | New Delhi, Delhi, India | |||
| Marc Laboratories Limitedthis company | ₹202.58 Cr (FY 2025) | ₹9.63 Cr | 4.8% | 3.0% | 341 | New Delhi, Delhi, India |
To see the full peer comparison of Marc Laboratories Limited, buy the company report.
Auditor
Marc Laboratories Limited is audited by Raj K Aggarwal & Associates for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Raj K Aggarwal & Associates | FY 2025 | 002585N/N500417 |
Shareholding
The shareholding of Marc Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Marc Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹155.67 Cr
Satisfied charges
₹123.09 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Aug 2024 | 100991082 | Hdfc Bank Limited | ₹9.48 Lakh | Open | |
| 16 Apr 2024 | 100903729 | Hdfc Bank Limited | ₹90.6 Cr | Open | |
| 27 Sep 2022 | 100619166 | Others | ₹40.5 Cr | Open | |
| 18 Aug 2020 | 100414252 | Axis Bank Limited | ₹2.3 Cr | Open | |
| 12 Jun 2018 | 100214334 | Axis Bank Limited | ₹22.18 Cr | Open |
To see the full charge records of Marc Laboratories Limited, buy the company report.
Total charge records: 20 View all charges
Deals & funding
Marc Laboratories Limited has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹3.35 Cr; the latest was in November 2024.
Total deals
7
Secondary share transfers
6
Funding round
1
Disclosed funding
₹3.35 Cr
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 4 individuals |
| Apr 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2012 | Funding round | ₹3.35 Cr | Investors: 4 individuals |
To see the full deal history of Marc Laboratories Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Marc Laboratories Limited has 47 court cases on record: 41 filed by Marc Laboratories, 6 filed against it. 19 cases are pending and 28 are disposed.
Total cases
47
Filed by the company
41
Filed against the company
6
Pending
19
Disposed
28
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 31 | 5 | 18 |
| High courts | 14 | 1 | 1 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 47)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMMP) | Filed by the company against Centaur Drug House Private Limited | Disposed |
| District court, Indore, Madhya Pradesh | Court case (MJC R) | Filed against the company by an individual | Pending |
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
| High Court of Madhya Pradesh | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
To see the full case history of Marc Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Marc Laboratories Limited was last rated by Icra on 23 Feb 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 23 Feb 2022 |
To see the full credit ratings and regulatory alerts of Marc Laboratories Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Marc Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Marc Laboratories has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Marc India Limited | U74899DL1994PLC056911 |
To see the full group structure of Marc Laboratories Limited, buy the company report.
Employees & EPFO
Marc Laboratories Limited has a workforce of 341 employees on its EPFO records as of Feb 09, 2026, across 1 active EPFO establishment.
Employee count
341
Active EPFO establishments
1
Employee growth
0.59%
GST
Marc Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Marc Laboratories Limited, buy the company report.
Recent activity
Marc Laboratories Limited has 13 board changes on record since 1985: 6 appointments and 7 cessations. The latest: Bimlesh Kumar Srivastava ceased to be Director on 20 Nov 2024.
Charges
A charge with Others of Rs. 40.50 Cr registered on 27 Sep 2022 with Charge ID 100619166 was modified on 20 Feb 2026.
AGM
Marc Laboratories Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Marc Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Bimlesh Kumar Srivastava ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.09 Cr with Charge ID 100991082 was registered on 27 Aug 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 90.60 Cr with Charge ID 100903729 was registered on 16 Apr 2024.
Ceased
Akhilesh Kumar Srivastava ceased to be Additional Director.
Ceased
Kapil Dev Mahto ceased to be Additional Director.
Ceased
Nitin Kishore Rastogi ceased to be Additional Director.
Ceased
Vipin Kishore Rastogi ceased to be Additional Director.
Appointed
Akhilesh Kumar Srivastava was appointed as Director.
Appointed
Kapil Dev Mahto was appointed as Director.
49 earlier events are in the company report.
Frequently asked questions
Marc Laboratories is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 1985 (41+ years old) and is registered under CIN U72200DL1985PLC020782.
Marc Laboratories has 6 current directors:
- Kapil Dev Mahto - Director
- Amit Kishore Rastogi - Director
- Vipin Kishore Rastogi - Director
- Prem Kishore Rastogi - Director
- Akhilesh Kumar Srivastava - Director
- Nitin Kishore Rastogi - Director
The latest financial statements of Marc Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Marc Laboratories has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Marc Laboratories is U72200DL1985PLC020782. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marc Laboratories has 47 court cases on record: 41 filed by the company and 6 filed against it. 19 are pending. Most are in the district courts.
Marc Laboratories was incorporated on 25 April 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Marc Laboratories has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹3.35 Cr; the latest was in November 2024.
The peers of Marc Laboratories by revenue are Rusan Pharma Limited, Zim Laboratories Limited, Rajasthan Antibiotics Ltd, Caplin Steriles Limited, Unicure India Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bimlesh Kumar Srivastava ceased to be Director on 20 Nov 2024. Akhilesh Kumar Srivastava ceased to be Additional Director on 29 Dec 2023. Kapil Dev Mahto ceased to be Additional Director on 29 Dec 2023. Marc Laboratories has 13 board changes on record in total.
Yes, Marc Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0002412).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages